Résultats de recherche
7 sept. 2022 · 7 September 2022, Cambridge, UK: STORM Therapeutics Ltd. (STORM), the biotechnology company discovering and developing novel small molecule therapies targeting RNA modification enzymes for oncology and other diseases, today announced the appointment of Dr. Gerald (Jerry) McMahon as President and Chief Executive Officer and Board ...
Jerry McMahon, PhD Chief Executive Officer & President Jerry has over 30 years of biotechnology leadership, scientific innovation, creative deal-making, and financing experience.
7 sept. 2022 · Industry veteran to lead STORM as it transitions into a clinical-stage company with a pipeline of products targeting RNA modifying enzymes. Dr. McMahon Joins as Board Director. CAMBRIDGE, England...
View Jerry McMahon’s profile on LinkedIn, a professional community of 1 billion members. Dr. McMahon brings more than 30 years of exceptional biotechnology leadership, scientific…
- STORM Therapeutics
23 nov. 2022 · Dr Jerry McMahon, CEO of STORM Therapeutics, said: “This is a major milestone for STORM as we enter clinical development with our lead candidate STC-15 and continue progressing a pipeline targeting RNA modifying enzymes beyond METTL3.
7 sept. 2022 · STORM Therapeutics Ltd. (STORM), the biotechnology company discovering and developing novel small molecule therapies targeting RNA modification enzymes for oncology and other diseases, today announced the appointment of Dr. Gerald (Jerry) McMahon as President and Chief Executive Officer and Board Director.
7 sept. 2022 · Harpoon’s McMahon becomes CEO at Storm. Plus new CFO, CSO at Voyager and updates from Sonoma, Garuda, Alloy, Homology and more. By Richard Guy, Biopharma Analyst, and Gunjan Ohri, Data Content Analyst. September 7, 2022 3:51 PM PDT. Storm Therapeutics Ltd. hir ed Jerry McMahon as CEO.
